21900-25-4

Basic information

• Product Name: 4-BROMO-3-METHYLBENZOYL CHLORIDE
• Synonyms: 4-BROMO-3-METHYLBENZOYL CHLORIDE
• CAS NO: 21900-25-4
• Molecular Formula: C₈H₆BrClO
• Molecular Weight: 233.49
• Mol File: 21900-25-4.mol
• Article Data: 21

Chemical Properties

• Melting Point: 27-28°C
• Boiling Point: 145°C 20mm
• Flash Point: 145°C/20mm
• Appearance: /
• Density: 1.574g/cm³
• Vapor Pressure: 0.00472mmHg at 25°C
• Refractive Index: 1.575
• Sensitive: Moisture Sensitive
• BRN: 2574147
• CAS DataBase Reference: 4-BROMO-3-METHYLBENZOYL CHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-3-METHYLBENZOYL CHLORIDE(21900-25-4)
• EPA Substance Registry System: 4-BROMO-3-METHYLBENZOYL CHLORIDE(21900-25-4)

Safety Data

• Hazard Codes: Xn,N
• Statements: 34-50-22
• Safety Statements: 26-36/37/39-45-61
• RIDADR: 3261
• HazardClass: 8
• PackingGroup: III
• Hazardous Substances Data: 21900-25-4(Hazardous Substances Data)

Usage

General Description

4-Bromo-3-methylbenzoyl chloride is a chemical compound with the formula C8H7BrOCl. It is a colorless to pale yellow liquid that is primarily used in the synthesis of pharmaceuticals and agrochemicals. In particular, it is a key intermediate in the production of nonsteroidal anti-inflammatory drugs (NSAIDs) such as Ibuprofen. 4-BROMO-3-METHYLBENZOYL CHLORIDE is also utilized in the preparation of various organic compounds and active pharmaceutical ingredients. It is important to handle 4-Bromo-3-methylbenzoyl chloride with caution, as it is a reactive and corrosive material that should be stored and used in a well-ventilated area with appropriate personal protective equipment.

InChI:InChI=1/C8H6BrClO/c1-5-4-6(8(10)11)2-3-7(5)9/h2-4H,1H3

Upstream product

• 7697-28-1 4-bromo-3-methylbenzoic acid 

Downstream Products

• 85588-37-0 3-methyl-4-bromo benzophenone 
• 185685-57-8 (4-Bromo-3-methyl-phenyl)-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-methanone 
• 170230-01-0 4-bromo-N-methoxy-3,N-dimethylbenzamide 
• 157672-20-3 2-(4-bromo-3-methylphenyl)oxazole 
• 85588-40-5 3-bromomethyl-4-bromobenzophenone 
• 85588-43-8 6-bromo-3-benzoylphenyl acetonitrile 
• 85588-46-1 2-(6-bromo-3-benzoylphenyl)propionitrile 
• 215587-28-3 6-Benzyloxy-2-(dimethylamino)benzo[b]thiophen-3-yl 4-Bromo-3-(methyl)phenyl Ketone 
• 843661-61-0 (4-bromo-3-methylphenyl)(4-methoxyphenyl)methanone 
• 1388069-86-0 2-amino-5-(4-bromo-3-methylphenyl)-1,3,4-thiadiazole 
• 473264-36-7 (4-Bromo-3-methyl-phenyl)-(4H,10H-3a,5,9-triaza-benzo[f]azulen-9-yl)-methanone 
• 473264-11-8 7,8-dimethoxy-(10,11-dihydro-5H-pyrrolo[2,1-c][1,4] benzodiazepin-10-yl)-(4-bromo-3-methyl-phenyl)-methanone 
• 1006878-24-5 C₁₅H₁₁BrN₂O 

Relevant articles and documents

Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 2. Ketone Linked Analogs

The optimization of a series of benzimidazole-benzoxaborole hybrid molecules linked via a ketone that exhibit good activity against Onchocerca volvulus, a filarial nematode responsible for the disease onchocerciasis, also known as river blindness, is desc

Studies on phenothiazines: New microtubule-interacting compounds with phenothiazine A-ring as potent antineoplastic agents

New phenothiazine derivatives 6-20 have been designed, synthesized and evaluated in vitro for their ability to inhibit tubulin polymerization and antiproliferative activity against 60 cancer cell lines, including several multi-drug resistant (MDR) tumor cell lines. The phenothiazine unit may successfully replace the classical 3,4,5-trimethoxyphenyle A ring of parent combretastatin A-4 or phenstatin, confirming previous studies. The most promising structural modulations have been realized on the B ring, the 2′-fluoro-4′-methoxy substitution in compound 6 and the 2′-trifluoromethyl-4′-methoxy substitution in compound 7 providing the best antitubulin and antitumor activity in the current study. Compounds 6-8 and 16 exhibited more important cell growth inhibition than parent phenstatin 2 on human colon Duke's type D, colorectal adenocarcinoma COLO 205 and on human kidney adenocarcinoma A498 cell lines. 10-Methylphenothiazine derivatives 19 and 20 did not show biological activity but exerted bright fluorescence and solvatochromism effects. These molecules deserve further chemical efforts in order to provide valuable tools for biophysical studies.

SUBSTITUTED TRIAZOLES AND THEIR USE FOR TREATMENT AND/OR PREVENTION NEUROLOGICAL AND PSYCHIATRIC DISORDERS

This invention relates to compounds of formula (I), their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R1, R2, R3 have meanings given in the description.